New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 Clinical Trials Supported by FDA Fast Track ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

Early detection is one of the best ways to improve lung cancer survival. It’s a message Northern Light Health is sharing in the fight against the leading cause of cancer death in the U.

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

LEXINGTON, Ky. Kentucky has historically led the nation in lung cancer rates, but the statistics are turning around thanks to ...

Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN ...

Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes.

Jefferies London Healthcare Conference 2025 November 18, 2025 10:30 AM ESTCompany ParticipantsDave Gancarz - Chief ...